| 2.24 Delayed Data As of Mar 02 |  -0.09 / -3.86%Today’s Change | 1.20 Today|||52-Week Range 3.03 | +38.27% Year-to-Date |
| 3 Pharmaceutical Stocks Set for Massive Earnings Growth in 2015 - Stocks in the News Mar 02 / Zacks.com | Zacks Rank #1 Additions for Tuesday - Tale of the Tape Feb 17 / Zacks.com |
| Zacks Rank #1 Additions for Tuesday - Tale of the Tape Feb 24 / Zacks.com |
| Previous close | 2.33 |
| Today’s open | 2.34 |
| Day’s range | 2.19 - 2.34 |
| Volume | 347,112 |
| Average volume (3 months) | 351,068 |
| Market cap | $91.1M |
| Dividend yield | -- |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| EVARLombard Medical Inc | +0.10 | +1.77% |
| VICLVical Inc | -0.03 | -2.95% |
| LPCNLipocine Inc | +0.64 | +8.84% |
| NEOTNeothetics Inc | -0.05 | -0.75% |
| Next reporting date | March 10, 2015 |
| EPS forecast (this quarter) | -$0.18 |
| Annual revenue (last year) | -- |
| Annual profit (last year) | -- |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters --, -- |
